Geometry.Net - Science: Gene Therapy


Home - Science - Gene Therapy

e99.com Bookstore

Images

Newsgroups

61-80 of 179 Back | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | Next 20

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Gene Therapy: more books (100)

Vascular Embolotherapy: A Comprehensive Approach, Volume 2: Oncology, Trauma, Gene Therapy, Vascular Malformations, and Neck (Medical Radiology / Diagnostic Imaging)
Gene Therapy (Ernst Schering Foundation Symposium Proceedings)
Progress in Gene Therapy: Pioneering Stem Cell/Gene Therapy Trials
Tumor Suppressing Viruses, Genes, and Drugs: Innovative Cancer Therapy Approaches
Gene Therapy and Ethics (Acta Universitatis Upsaliensis: Studies in Bioethics & Research Ethics, 4)
The 2009 Report on Gene Therapy: World Market Segmentation by City by Icon Group International, 2009-07-06
30th Hemophilia Symposium Hamburg 1999: HIV Infection and Epidemiology in Hemophilia; Gene Therapy in Hemophilia A and B; Therapy of Hepatitis C; Inhibitors ... Pediatric Hemostasiology; Case Reports
Gene Therapy for Neurological Disorders & Brain Tumors (Contemporary Neuroscience)
Cancer Gene Therapy: Past Achievements and Future Challenges
The 2009-2014 Outlook for Gene Therapy in Greater China by Icon Group International, 2009-07-07
The 2009-2014 Outlook for Gene Therapy in The Middle East & Africa by Icon Group International, 2009-05-29
Gene Therapy in Cancer (Basic and Clinical Oncology)
The 2009-2014 Outlook for Gene Therapy in Europe by Icon Group International, 2009-05-28
The promise of gene therapy.(Guest Editorial): An article from: Pediatric News by Joseph C., III Glorioso, 2004-03-01

lists with details

UMHS Center For Gene Therapy
The center links basic science, clinical investigation and technology transfer endeavors in the area of gene therapy, while also serving as a resource for information and education.
http://www.med.umich.edu/cgt/

Extractions: The Center for Gene Therapy at the University of Michigan Medical Center was created to link basic science, clinical investigation and technology transfer. The Center fosters a multidisciplinary approach to new research as well as collaborative research endeavors in the area of gene therapy; extends the services of existing and newly created research cores to investigators; and serves as a resource for information and education. Scope of Activities To aid medical researchers, we have divided the Center into four programs. Each program offers products and services to aid the medical researcher here at Michigan and elsewhere. The products and services are : Gene Vector Program
Archport Ltd. Home Page Bio-Pharmaceutical Contract Manufacturing
Provides contract production and R D services (including animal cell fermentation and downstream processing) to the biopharmaceutical/biotechnology industry, of recombinant proteins. Indepth information on suspension, microcarriers, perfusion, batch fermentation, and gene therapy applications.
http://www.archport.ie
Human Gene Therapy
Publishes scientific papers on original investigations into the transfer and expression of genes in mammals, including humans. Subscription based.
http://www.liebertpub.com/hum/

Extractions: Select Subscription Rate: -Personal Rates- 2004 Online Only Personal $699.00 2004 Outside USA Print Personal $1,075.00 2004 USA Print Personal $746.00 -Institutional Rates- 2004 Online Only Institutional $1,899.00 2004 Outside USA Print Institutional $2,245.00 2004 USA Print and Online Institutional $2,379.00 2004 USA Print Institutional $1,988.00 Please note subscription orders are entered for the complete volume year. For example, if you are ordering the 2004 volume, you will receive any and all issues published to date for that volume. HUMAN GENE THERAPY LAUNCHES ELECTRONIC MANUSCRIPT SUBMISSION AND PEER REVIEW EFFECTIVE MAY 24, 2004
Harvard Gene Therapy Initiative
gene therapy Initiative, Harvard Institute of Human Genetics, Harvard Medical School, Children s Hospital, Boston. Conducts research
http://hgti.med.harvard.edu/
Transgene
Discovers and develops gene therapy technologies and products for the treatment of acquired or inherited diseases for which there is no cure or adequate therapy at present. (Nasdaq TRGNY).
http://www.transgene.fr/
LSUSU Gene Therapy Program
The gene therapy Program is located in the Department of Medicine and affiliated with the Stanley S. Scott Cancer Center and the Center for Human and Molecular Genetics at Louisiana State University Health Sciences Center at New Orleans. The major aim of the LSUHSC gene therapy Program is to develop new therapies for a series of genetic and acquired diseases including Cystic Fibrosis, Hemophilia, Krabbe's Disease and infectious diseases such as AIDS, TB, and pneumonia.
http://www.medschool.lsumc.edu/GeneTherapy/Default.htm
BBC News | HEALTH | 'Bubble Boy' Saved By Gene Therapy
In one of the first treatments of its kind, UK doctors have used gene therapy to cure a toddler of a potentially fatal disorder. gene therapy hurdles.
http://news.bbc.co.uk/hi/english/health/newsid_1906000/1906999.stm

Extractions: In one of the first treatments of its kind, UK doctors have used gene therapy to cure a toddler of a potentially fatal disorder. Scientists at Great Ormond Street Hospital in London successfully treated 18-month-old Rhys Evans, who had a condition preventing him from developing an immune system. The problem, called severe combined immunodeficiency (SCID) is caused by a single mutated gene, and meant that he had to live in sterile conditions or risk picking up a life-threatening infection.
Richard Taylor : Functional Viral Formulation : 27/05/04
Interests in virology, molecular biology, biochemical engineering. Current work is on functional formulation of gene therapy vectors and vaccines. University of Cambridge, UK.
http://www.cheng.cam.ac.uk/groups/biosci/rt.html

Extractions: BioScience Engineering Group University of Cambridge Department of Chemical Engineering BioScience Group Front Page ... Contact Richard Taylor Researcher in Bioscience Engineering Richard Taylor graduated from Imperial College, London, with a BSc in Biochemistry in 2001 before moving to Cambridge. He is currently completing a PhD on the functional formulation of viral and DNA based gene therapeutics and is expecting to be in a position to leave Cambridge by October 2004. He holds a BBSRC Industrial CASE Studentship, and works with the cooperating company : Nektar Therapeutics , in Bradford. Details of current work can be found on Richard Taylor's Research page Further personal information can be obtained by following the links on the left of this page. In addition to research work, he teaches undergraduate students, in Medical and Natural Sciences Biochemistry and Molecular Cell Biology ) Working with students from Queens,
BBC NEWS | Health | Gene Therapy May Block HIV Spread
gene therapy may block HIV spread. SEE ALSO gene therapy breakthrough 24 Feb 03 Health. Gene offers HIV drug success 06 Jan 02 Health.
http://news.bbc.co.uk/2/hi/health/3707463.stm

Extractions: There is no cure for HIV Three people with HIV have had a new experimental treatment to try to help them fight the disease. Scientists in the United States have used gene therapy techniques to try to boost their immune systems. Initial results from the trial have been promising, according to a report in New Scientist magazine. VIRxSYS, the company behind the technique, says it will test it on another two patients shortly, before embarking on a larger trial. Re-engineered cells The technique involves taking T cells from patients and re-engineering them so that they can destroy HIV. T cells are a type of white blood cell that can identify and destroy invading viruses. This is probably the most exciting of the anti-HIV strategies around at the moment Oxford BioMedica These cells are treated with a "gutted" form of HIV in the laboratory, which has been genetically engineered to stop HIV in the body from replicating and spreading. After the cells have been treated in this way, they are re-introduced into the body where they lie in wait until HIV attacks.
CNN.com - Health - New Plans Unveiled To Protect Gene Therapy Patients - March 7
http://www.cnn.com/2000/HEALTH/03/07/gene.therapy/index.html

Extractions: Web posted at: 5:31 p.m. EST (2231 GMT) WASHINGTON (CNN) The Food and Drug Administration and the National Institutes of Health Tuesday announced two initiatives designed to better ensure the safety of patients who take part in gene therapy trials. The FDA is implementing a Gene Therapy Clinical Trial Monitoring Plan and the NIH is sponsoring a series of Gene Transfer Symposia. Both initiatives are designed to enhance current safety standards for patients enrolled in gene therapy trials.
Current Gene Therpy Editorial Page
Online Articles PayPer-View. CURRENT. gene therapy. SCOPE OBJECTIVES. Barry J. Byrne. (gene therapy Center, Gainesville, FL, USA). Lung-Ji Chang.
http://www.bentham.org/cgt/index2.htm

Extractions: Forthcoming Articles Instructions for Authors Read the First issue on-line ... Online Articles: Pay-Per-View CURRENT GENE THERAPY Current Gene Therapy is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews on all aspects of gene therapy. The journal is aimed at all academic and industrial scientists who are interested in understanding either the pre-clinical or clinical research on gene therapy. The journal will serve as an expert forum to convey all the latest research on gene transfer and gene expression analysis, animal models, vector development and human clinical applications for the treatment of disease. Ignacio Anegon INSERM unit 437 30, boulevard Jean Monnet 44093 Nantes France FOUNDING EDITOR Pedro R. Lowenstein Gene Therapeutics Research Institute Los Angeles, CA, USA Ian E. Alexander (Children's Hospital at Westmead, Westmead, NSW, Australia) Arthur L. Beaudet (Baylor College of Medicine, Houston, TX, USA) Vincenzo Bronte (Dept. of Oncology and Surgical Sci., Padova, Italy)
CNN - Father Of Gene Therapy Participant Says Researchers Acted 'irresponsibly'
http://www.cnn.com/2000/HEALTH/02/02/gene.therapy.02/index.html

Extractions: Web posted at: 3:42 p.m. EST (2042 GMT) From Medical Correspondent Elizabeth Cohen (CNN) The father of a young man who died during a gene therapy trial at the University of Pennsylvania told a Senate hearing on Wednesday that researchers acted "irresponsibly" and they downplayed possible risks to his son. Paul Gelsinger testified during the Senate Health, Education and Labor Subcommittee hearing on whether the Food and Drug Administration did the right thing in shutting down gene therapy trials at the University of Pennsylvania after 18-year-old Jesse Gelsinger of Tucson, Arizona, died in September.
CNN.com - Gene Therapy Hope For Cancer Patients - August 1, 2000
http://www.cnn.com/2000/HEALTH/08/01/gene/index.html

Extractions: WEB SERVICES: Scientists said the virus helped to destroy some cancer cells LONDON A gene therapy that has shrunk and even eradicated tumors in dying patients is being hailed by scientists as a significant breakthrough in the fight against cancer. The therapy works by using a genetically engineered virus to home in on and then destroy cancer cells.
New Scientist
gene therapy fights HIV in human tests. 1357 13 May 04. Related Stories. Alzheimer s gene therapy trial shows early promise 28 April 2004.
http://www.newscientist.com/news/news.jsp?id=ns99994982
University's Gene Therapy Lab Won't Perform Research On Humans
http://cnn.com/2000/HEALTH/05/25/genetherapy.ap/index.html
New Scientist
Alzheimer s gene therapy trial shows early promise. The first gene therapy trial for Alzheimer s disease has delivered promising early results.
http://www.newscientist.com/news/news.jsp?id=ns99994930
Collateral Therapeutics
Develops nonsurgical gene therapy products for treating cardiovascular diseases, including coronary artery disease, peripheral vascular disease, congestive heart failure and heart attack. Product developments, video, and contacts.
http://www.collateralthx.com/
CNN - Gene Therapy Researchers Defend Trial After Death Of Patient - December 10
http://www.cnn.com/1999/HEALTH/12/10/gene.therapy.01/index.html

Extractions: From Medical Correspondent Pete Hartogs BETHESDA, Maryland (CNN) Researchers who led the gene therapy trial that left an 18-year-old man dead have defended their work to government investigators. Jesse Gelsinger of Tucson, Arizona, died in September after receiving an experimental gene therapy at the University of Pennsylvania for an inherited liver disease.
Gene Therapy: Molecular Bandage?
What is gene therapy? The what and why of gene therapy research. Choosing Targets for gene therapy See how researchers decide which
http://gslc.genetics.utah.edu/units/genetherapy/
CNN.com - Health - Gene Therapy Research Targets Muscular Dystrophy - November 2
http://cnn.com/2000/HEALTH/11/27/muscular.dystrohpy/index.html

Extractions: CNN.com Health Writer (CNN) Imagine a virus that makes you well. Scientists at the University of Pittsburgh in Pennsylvania are zeroing in on the muscle-wasting disease of Duchenne Muscular Dystrophy using a genetically altered virus called an adeno-associated virus. Researchers hope the tiny package will eventually carry a healing punch.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

61-80 of 179 Back | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | Next 20